In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Consumer confidence is up, but savings is down, which will curb first-time buyers' housing demand.
This biopharma company's Relistor drug should send revenues sharply higher this year.
This biopharma company's Relistor drug should send revenues sharply higher next year.
Traders, investors see demand as a function of confidence rather than capacity.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.